| Literature DB >> 33633743 |
Alice Tomlinson1,2,3, Jean-Philippe Semblat1,2,3, Benoît Gamain1,2,3, Arnaud Chêne1,2,3.
Abstract
Over 30 million women living in P. falciparum endemic areas are at risk of developing malaria during pregnancy every year. Placental malaria is characterized by massive accumulation of infected erythrocytes in the intervillous space of the placenta, accompanied by infiltration of immune cells, particularly monocytes. The consequent local inflammation and the obstruction of the maternofetal exchanges can lead to severe clinical outcomes for both mother and child. Even if protection against the disease can gradually be acquired following successive pregnancies, the malaria parasite has developed a large panel of evasion mechanisms to escape from host defense mechanisms and manipulate the immune system to its advantage. Infected erythrocytes isolated from placentas of women suffering from placental malaria present a unique phenotype and express the pregnancy-specific variant VAR2CSA of the Plasmodium falciparum Erythrocyte Membrane Protein (PfEMP1) family at their surface. The polymorphic VAR2CSA protein is able to mediate the interaction of infected erythrocytes with a variety of host cells including placental syncytiotrophoblasts and leukocytes but also with components of the immune system such as non-specific IgM. This review summarizes the described VAR2CSA-mediated host defense evasion mechanisms employed by the parasite during placental malaria to ensure its survival and persistence.Entities:
Keywords: PfEMP1; Plasmodium falciparum; VAR2CSA; VAR2CSA polymorphism; immune evasion; immuno-modulation; placental malaria
Year: 2021 PMID: 33633743 PMCID: PMC7900151 DOI: 10.3389/fimmu.2020.624126
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561